«Karnofsky Performance Status

Below is an extended Karnofsky Performance Status patents listing. Click here to return to the Karnofsky Performance Status main in depth entry.

Patents :
US Patent No.	Title
6080399	Vaccine adjuvants for immunotherapy of melanoma
6509321	Treatment of Kaposi's sarcoma with IL-12
6544787	Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantation
6551623	Immunomodulating compositions from bile
6573253	Methods for the administration of amifostine and related compounds
6596319	Immunomodulating compositions for treatment of immune system disorders
6627196	Dosages for treatment with anti-ErbB2 antibodies
6644320	Treatment of hepatitis C using hyperthermia
6677322	Use of mometasone furoate for treating airway passage and lung diseases
6677323	Use of mometasone furoate for treating airway passage and lung diseases
6703050	Methods and compositions for the prevention or treatment of cancer
6485759	Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same
6444638	Combinations of PKC inhibitors and therapeutic agents for treating cancers
6423308	Treatment of Kaposi's sarcoma with IL-12
6096313	Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
6147055	Cancer treatment method utilizing plasmids suitable for IL-2 expression
6262054	Combination therapy method for treating breast cancer using edatrexate
6277368	Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
6280774	Immunomodulating compositions from bile
6309632	Methods for treating HIV-infected patients by administering GM-CSF
6347633	Treatment of hepatitis C using hyperthermia
6365581	Use of mometasone furoate for treating airway passage and lung diseases
6399588	Cancer treatment method utilizing plasmids suitable for IL-2 expression
6415797	Treatment of human herpesviruses using hyperthermia
6713054	Cellular immunotherapy treatment of patients afflicted with chronic fatigue syndrome
6716422	Vaccine adjuvants for immunotherapy of melanoma
7148257	Methods of treating mesothelioma with suberoylanilide hydroxamic acid
7157570	Human ribonucleotide reductase M2 subunit
7175839	Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
7264820	Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline
7285279	Method of treating malignancies and viral infections and improving immune function with a dietary supplement
7344738	Herbal composition for treatment of immunocompromised conditions
7364726	Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
7371379	Dosages for treatment with anti-ErbB2 antibodies
7375137	Methods of treating cancer with HDAC inhibitors
7399787	Methods of treating cancer with HDAC inhibitors
7053072	Methods for the administration of amifostine and related compounds
7045495	Combination of bryostatin and paclitaxel for treating cancer
7014856	Ganglioside-KLH conjugate vaccines plus OS-21
6723713	Use of mometasone furoate for treating upper airway diseases
6773897	Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
6916476	Ganglioslide-KLH conjugate vaccine plus QS-21
6936253	Ganglioside-KLH conjugate vaccines plus QS-21
6943192	Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
6949532	Use of mometasone furoate for treating airway passage and lung diseases
6951219	Treatment of hepatitis C using hyperthermia
6956030	Use of mometasone furoate for treating upper airway diseases
6967022	Ganglioside-KLH conjugate vaccines plus QS-21
6984720	Human CTLA-4 antibodies
7425565	Use of benzothiopenes to treat and prevent prostate cancer

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.